Artwork

コンテンツは Cynthia Thurlow, Everyday Wellness: Cynthia Thurlow, and NP によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Cynthia Thurlow, Everyday Wellness: Cynthia Thurlow, and NP またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal
Player FM -ポッドキャストアプリ
Player FMアプリでオフラインにしPlayer FMう!

Ep. 367 The Metabolic Health Crisis & GLP-1s with Dr. Anurag Singh

42:00
 
シェア
 

Manage episode 422044181 series 2437481
コンテンツは Cynthia Thurlow, Everyday Wellness: Cynthia Thurlow, and NP によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Cynthia Thurlow, Everyday Wellness: Cynthia Thurlow, and NP またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal

I am delighted to reconnect with Dr. Anurag Singh today, the Chief Medical Officer at Timeline Nutrition. He joined me once before on Episode 268.

I invited Dr. Singh back to discuss the latest research on GLP-1 agonists like Wegovy, Semaglutide, and Ozempic, which are gaining significant traction with projected sales exceeding $100 billion by 2030, potentially affecting 9% of the US population.

In our conversation, we explore the contributors to our metabolic health crisis by looking at the research surrounding GLP-1 agonists, the physiology of GLP-1 peptides, and the influencing elements Dr. Singh refers to as the trifecta. We dive into the loss of muscle mass and strength, sarcopenia, and frailty associated with these drugs, and Dr. Singh shares his concerns about their impact on bone health, the gut microbiome, and their use in younger patients. We also get into lifestyle measures, mitochondrial health, hallmarks of aging, Akkermansia, and the importance of advocacy and patient empowerment.

Today’s compelling and invaluable discussion with Dr. Anurag Singh highlights crucial insights into GLP-1 agonists and their broader health implications. I know it will provide significant value for our listeners.

IN THIS EPISODE YOU WILL LEARN:

  • Dr. Singh breaks down what GLP-1 agonist drugs are and how they work.
  • How our modern-day lifestyles contribute to poor metabolic health
  • The benefits and side-effects of using GLP-1 agonist treatments for improving metabolic health
  • Why strength training is essential for preventing muscle loss and frailty in middle-aged women
  • What are the potential long-term effects of SARMs on muscle mass and health?
  • Why dietary counseling is essential for those taking GLP-1 agonist drugs
  • The benefits of supplements for boosting mitochondrial health
  • Dr. Singh discusses a research study on combining lithium with GLP-1 agonists to improve the muscle quality of those with muscle-wasting conditions.
  • Why akkermansia is essential for GLP production

Connect with Cynthia Thurlow

Connect with Dr. Anurag Singh

Previous Episode Mentioned

Ep. 268: Understanding the Biology of Aging with Evolved Supplementation and Nutrition, featuring Dr. Anurag Singh

  continue reading

391 つのエピソード

Artwork
iconシェア
 
Manage episode 422044181 series 2437481
コンテンツは Cynthia Thurlow, Everyday Wellness: Cynthia Thurlow, and NP によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Cynthia Thurlow, Everyday Wellness: Cynthia Thurlow, and NP またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal

I am delighted to reconnect with Dr. Anurag Singh today, the Chief Medical Officer at Timeline Nutrition. He joined me once before on Episode 268.

I invited Dr. Singh back to discuss the latest research on GLP-1 agonists like Wegovy, Semaglutide, and Ozempic, which are gaining significant traction with projected sales exceeding $100 billion by 2030, potentially affecting 9% of the US population.

In our conversation, we explore the contributors to our metabolic health crisis by looking at the research surrounding GLP-1 agonists, the physiology of GLP-1 peptides, and the influencing elements Dr. Singh refers to as the trifecta. We dive into the loss of muscle mass and strength, sarcopenia, and frailty associated with these drugs, and Dr. Singh shares his concerns about their impact on bone health, the gut microbiome, and their use in younger patients. We also get into lifestyle measures, mitochondrial health, hallmarks of aging, Akkermansia, and the importance of advocacy and patient empowerment.

Today’s compelling and invaluable discussion with Dr. Anurag Singh highlights crucial insights into GLP-1 agonists and their broader health implications. I know it will provide significant value for our listeners.

IN THIS EPISODE YOU WILL LEARN:

  • Dr. Singh breaks down what GLP-1 agonist drugs are and how they work.
  • How our modern-day lifestyles contribute to poor metabolic health
  • The benefits and side-effects of using GLP-1 agonist treatments for improving metabolic health
  • Why strength training is essential for preventing muscle loss and frailty in middle-aged women
  • What are the potential long-term effects of SARMs on muscle mass and health?
  • Why dietary counseling is essential for those taking GLP-1 agonist drugs
  • The benefits of supplements for boosting mitochondrial health
  • Dr. Singh discusses a research study on combining lithium with GLP-1 agonists to improve the muscle quality of those with muscle-wasting conditions.
  • Why akkermansia is essential for GLP production

Connect with Cynthia Thurlow

Connect with Dr. Anurag Singh

Previous Episode Mentioned

Ep. 268: Understanding the Biology of Aging with Evolved Supplementation and Nutrition, featuring Dr. Anurag Singh

  continue reading

391 つのエピソード

すべてのエピソード

×
 
Loading …

プレーヤーFMへようこそ!

Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。

 

クイックリファレンスガイド